Nifty
Sensex
:
:
14371.90
48878.54
-218.45 (-1.50%)
-746.22 (-1.50%)

Pharmaceuticals & Drugs - Global

Rating :
60/99  (View)

BSE: 540025 | NSE: ADVENZYMES

308.90
-5.30 (-1.69%)
22-Jan-2021 | 4:00PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  315.05
  •  319.05
  •  306.60
  •  314.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  127432
  •  393.64
  •  384.70
  •  98.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,452.27
  • 26.52
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,393.68
  • 0.19%
  • 3.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.39%
  • 2.64%
  • 14.14%
  • FII
  • DII
  • Others
  • 17.11%
  • 6.24%
  • 4.48%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.35
  • 8.61
  • 4.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.34
  • 8.11
  • 4.43

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.73
  • 11.26
  • 12.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 26.13
  • 18.74

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 6.67
  • 3.27

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 17.16
  • 12.06

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
120.39
111.44
8.03%
110.50
110.34
0.15%
110.26
110.42
-0.14%
111.94
101.74
10.03%
Expenses
61.87
64.17
-3.58%
58.77
56.85
3.38%
61.56
60.71
1.40%
59.07
60.01
-1.57%
EBITDA
58.51
47.27
23.78%
51.73
53.49
-3.29%
48.70
49.70
-2.01%
52.87
41.73
26.70%
EBIDTM
48.60%
42.41%
46.81%
48.48%
14.01%
14.01%
47.23%
41.01%
Other Income
0.58
1.54
-62.34%
5.23
1.06
393.40%
1.84
2.64
-30.30%
1.21
0.34
255.88%
Interest
0.39
0.74
-47.30%
0.46
0.82
-43.90%
0.69
0.58
18.97%
0.79
0.00
0.00
Depreciation
6.80
6.47
5.10%
6.72
6.26
7.35%
6.65
5.28
25.95%
6.39
5.41
18.11%
PBT
51.91
41.60
24.78%
49.78
47.47
4.87%
43.20
46.48
-7.06%
46.89
36.66
27.91%
Tax
13.35
9.75
36.92%
14.98
13.50
10.96%
10.52
13.03
-19.26%
12.33
11.32
8.92%
PAT
38.56
31.84
21.11%
34.80
33.97
2.44%
32.68
33.46
-2.33%
34.56
25.35
36.33%
PATM
32.03%
28.57%
31.50%
30.79%
7.11%
7.11%
30.87%
24.91%
EPS
3.33
2.77
20.22%
3.07
2.99
2.68%
28.29
28.29
0.00%
3.01
2.19
37.44%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
453.09
443.99
419.59
391.01
328.99
293.76
223.11
239.45
220.42
171.74
116.11
Net Sales Growth
4.41%
5.82%
7.31%
18.85%
11.99%
31.67%
-6.82%
8.63%
28.35%
47.91%
 
Cost Of Goods Sold
4,703.72
80.91
77.24
81.47
71.03
61.67
47.72
47.61
52.11
48.29
47.02
Gross Profit
-4,250.63
363.08
342.35
309.54
257.96
232.09
175.39
191.85
168.31
123.44
69.10
GP Margin
-938.14%
81.78%
81.59%
79.16%
78.41%
79.01%
78.61%
80.12%
76.36%
71.88%
59.51%
Total Expenditure
241.27
240.85
237.03
227.48
177.54
156.20
132.59
138.32
129.72
109.54
93.12
Power & Fuel Cost
-
19.37
19.63
18.40
13.20
10.17
10.13
14.89
15.64
12.67
9.04
% Of Sales
-
4.36%
4.68%
4.71%
4.01%
3.46%
4.54%
6.22%
7.10%
7.38%
7.79%
Employee Cost
-
80.19
78.05
68.59
50.70
44.50
36.52
32.75
26.85
20.13
13.38
% Of Sales
-
18.06%
18.60%
17.54%
15.41%
15.15%
16.37%
13.68%
12.18%
11.72%
11.52%
Manufacturing Exp.
-
16.86
11.89
12.36
9.50
10.98
10.70
4.02
6.27
4.82
7.24
% Of Sales
-
3.80%
2.83%
3.16%
2.89%
3.74%
4.80%
1.68%
2.84%
2.81%
6.24%
General & Admin Exp.
-
26.05
31.65
28.03
18.05
15.72
17.63
21.22
17.88
12.56
10.12
% Of Sales
-
5.87%
7.54%
7.17%
5.49%
5.35%
7.90%
8.86%
8.11%
7.31%
8.72%
Selling & Distn. Exp.
-
10.56
9.66
9.57
7.55
7.29
5.87
5.41
4.57
3.77
4.98
% Of Sales
-
2.38%
2.30%
2.45%
2.29%
2.48%
2.63%
2.26%
2.07%
2.20%
4.29%
Miscellaneous Exp.
-
6.91
8.92
9.04
7.50
5.86
4.02
12.43
6.40
7.29
4.98
% Of Sales
-
1.56%
2.13%
2.31%
2.28%
1.99%
1.80%
5.19%
2.90%
4.24%
1.15%
EBITDA
211.81
203.14
182.56
163.53
151.45
137.56
90.52
101.13
90.70
62.20
22.99
EBITDA Margin
46.75%
45.75%
43.51%
41.82%
46.03%
46.83%
40.57%
42.23%
41.15%
36.22%
19.80%
Other Income
8.86
5.88
5.72
2.79
2.79
1.29
2.56
1.93
3.60
3.26
3.58
Interest
2.33
4.08
5.20
9.06
4.43
7.86
9.26
13.19
9.55
12.24
2.50
Depreciation
26.56
25.78
21.12
18.30
12.76
8.72
9.02
9.98
7.43
5.50
4.98
PBT
191.78
179.16
161.96
138.97
137.05
122.28
74.81
79.88
77.32
47.73
19.09
Tax
51.18
46.11
46.06
45.41
44.11
41.43
23.00
7.45
26.45
13.49
2.22
Tax Rate
26.69%
25.74%
28.44%
32.68%
32.19%
35.06%
30.74%
26.19%
34.21%
28.35%
11.63%
PAT
140.60
129.30
111.06
90.16
91.52
75.85
50.98
19.73
49.82
33.75
16.68
PAT before Minority Interest
137.72
133.05
115.90
93.56
92.94
76.75
51.81
21.00
50.88
34.08
16.87
Minority Interest
-2.88
-3.75
-4.84
-3.40
-1.42
-0.90
-0.83
-1.27
-1.06
-0.33
-0.19
PAT Margin
31.03%
29.12%
26.47%
23.06%
27.82%
25.82%
22.85%
8.24%
22.60%
19.65%
14.37%
PAT Growth
12.82%
16.42%
23.18%
-1.49%
20.66%
48.78%
158.39%
-60.40%
47.61%
102.34%
 
Unadjusted EPS
12.59
11.58
9.94
8.07
8.19
6.79
4.56
1.77
4.46
3.02
1.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
839.65
678.85
559.08
464.05
278.09
211.98
167.43
163.38
96.82
63.28
Share Capital
22.34
22.33
22.33
22.33
21.77
21.77
21.77
21.77
20.73
20.73
Total Reserves
813.71
652.99
534.12
441.42
256.32
190.21
145.67
141.62
76.09
42.55
Non-Current Liabilities
44.19
35.25
42.84
32.22
56.11
64.41
93.92
129.96
146.18
44.01
Secured Loans
3.44
5.55
17.42
16.18
34.53
49.02
81.95
108.30
132.08
27.77
Unsecured Loans
0.72
1.49
2.41
3.31
4.23
4.98
5.96
8.42
7.31
9.24
Long Term Provisions
1.30
0.55
1.12
0.79
0.18
0.00
0.00
0.00
0.00
0.00
Current Liabilities
59.55
65.12
102.89
65.26
110.76
130.71
132.61
100.14
104.76
45.43
Trade Payables
9.64
9.69
17.47
11.01
11.54
11.69
10.48
17.00
18.31
8.36
Other Current Liabilities
33.52
28.96
41.98
24.90
59.29
82.63
59.70
43.63
42.29
7.07
Short Term Borrowings
12.74
21.34
37.81
26.54
29.63
23.65
39.07
32.86
37.93
27.27
Short Term Provisions
3.64
5.12
5.63
2.80
10.29
12.74
23.36
6.66
6.23
2.73
Total Liabilities
971.19
805.18
727.41
582.67
450.31
411.55
397.59
396.03
349.35
153.98
Net Block
567.69
500.28
491.29
421.36
285.46
282.15
114.94
115.86
49.69
51.38
Gross Block
680.48
591.28
560.96
445.12
357.86
346.14
171.75
162.66
89.13
86.81
Accumulated Depreciation
112.80
91.00
69.67
23.77
72.40
63.99
56.81
46.79
39.44
35.43
Non Current Assets
595.61
523.12
511.88
439.68
310.59
307.44
305.55
302.23
272.59
90.12
Capital Work in Progress
10.13
10.49
10.54
8.05
6.90
9.15
173.44
173.05
214.95
18.86
Non Current Investment
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Long Term Loans & Adv.
16.68
11.27
8.93
9.08
18.04
16.03
7.80
12.17
7.79
19.82
Other Non Current Assets
1.05
1.01
1.06
1.13
0.13
0.04
9.31
1.09
0.09
0.00
Current Assets
375.57
282.06
215.53
142.98
139.72
104.11
92.04
93.80
76.76
63.85
Current Investments
123.53
110.98
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
80.03
76.90
75.57
68.48
60.49
52.63
49.93
44.59
29.08
17.87
Sundry Debtors
74.69
58.73
58.59
49.82
41.80
37.04
32.38
38.81
32.34
22.36
Cash & Bank
83.02
23.41
61.42
7.87
26.31
4.34
2.65
3.42
5.25
14.88
Other Current Assets
14.30
9.30
13.31
7.88
11.11
10.10
7.08
6.98
10.09
8.75
Short Term Loans & Adv.
6.56
2.74
6.62
8.93
3.30
9.38
7.02
6.68
10.04
8.74
Net Current Assets
316.03
216.94
112.64
77.72
28.96
-26.59
-40.57
-6.34
-28.00
18.43
Total Assets
971.18
805.18
727.41
582.66
450.31
411.55
397.59
396.03
349.35
153.97

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
140.90
128.56
115.97
107.35
93.40
53.73
55.57
41.12
88.37
1.18
PBT
179.16
161.96
138.97
137.05
118.18
74.81
28.45
77.32
47.58
19.09
Adjustment
28.23
26.02
27.15
18.31
15.35
17.22
20.68
15.29
16.53
6.02
Changes in Working Capital
-15.60
-12.10
-5.64
4.43
-13.10
-11.90
25.81
-26.07
36.74
-19.45
Cash after chg. in Working capital
191.79
175.88
160.48
159.80
120.43
80.12
74.95
66.54
100.85
5.66
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-50.89
-47.32
-44.51
-52.45
-27.03
-26.39
-19.38
-25.41
-12.48
-4.49
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-44.50
-124.65
-78.19
-60.35
-4.73
-11.39
-9.04
-29.52
-200.01
-18.26
Net Fixed Assets
-41.24
-9.42
-9.47
62.33
-5.70
-5.80
-5.78
-14.05
-40.93
Net Investments
-0.38
-0.43
-16.62
-50.33
-25.76
0.70
-0.06
-14.24
-8.85
Others
-2.88
-114.80
-52.10
-72.35
26.73
-6.29
-3.20
-1.23
-150.23
Cash from Financing Activity
-38.55
-43.09
-2.07
-65.30
-62.58
-36.33
-33.14
-4.54
99.94
30.10
Net Cash Inflow / Outflow
57.85
-39.17
35.72
-18.30
26.09
6.00
13.38
7.06
-11.70
13.01
Opening Cash & Equivalents
23.06
61.13
7.50
25.30
4.21
2.30
3.42
5.25
14.77
1.87
Closing Cash & Equivalent
82.66
23.06
61.13
7.54
25.30
4.25
2.30
3.42
5.25
14.88

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
74.86
60.49
49.85
41.54
25.55
19.48
15.38
15.01
9.34
6.10
ROA
14.98%
15.13%
14.28%
18.00%
17.81%
12.81%
5.29%
13.65%
13.54%
10.95%
ROE
17.61%
18.82%
18.34%
25.06%
31.32%
27.31%
12.70%
39.10%
42.58%
26.65%
ROCE
23.21%
24.96%
25.88%
31.53%
35.68%
25.49%
12.25%
26.71%
27.73%
16.81%
Fixed Asset Turnover
0.70
0.73
0.79
0.85
0.86
0.90
1.48
1.83
2.03
1.42
Receivable days
54.84
51.03
50.00
48.73
47.26
54.62
52.34
56.37
55.96
66.28
Inventory Days
64.51
66.32
66.44
68.60
67.81
80.70
69.50
58.35
48.02
52.97
Payable days
14.50
22.85
24.79
25.01
28.70
33.75
39.49
56.24
49.33
36.08
Cash Conversion Cycle
104.84
94.50
91.65
92.33
86.37
101.56
82.35
58.48
54.65
83.17
Total Debt/Equity
0.03
0.05
0.12
0.12
0.36
0.54
0.99
1.13
2.13
1.03
Interest Cover
44.94
32.13
16.34
31.91
16.04
9.08
3.16
9.09
4.89
8.64

News Update


  • Advanced Enzymes gets nod to invest Rs 316.26 million in SciTech Specialties
    28th Dec 2020, 09:07 AM

    On completion of the aforesaid investment, SSPL will become subsidiary of the company

    Read More
  • Advanced Enzyme - Quarterly Results
    12th Nov 2020, 12:18 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.